BioLife Solutions

Bothell, WA-based BioLife Solutions, Inc. is a developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers.

Company Growth (employees)
Type
Public
HQ
Bothell, US
Founded
1987
Size (employees)
35 (est)-18%
BioLife Solutions was founded in 1987 and is headquartered in Bothell, US

BioLife Solutions Office Locations

BioLife Solutions has an office in Bothell
Bothell, US (HQ)
310 3303 Monte Villa Pkwy

BioLife Solutions Data and Metrics

BioLife Solutions Financial Metrics

BioLife Solutions's revenue was reported to be $6.4 m in FY, 2015
USD

Net income (Q1, 2017)

(870.3 k)

EBIT (Q1, 2017)

(464 k)

Market capitalization (25-Jul-2017)

42.5 m

Cash (31-Mar-2017)

2.3 m
BioLife Solutions's current market capitalization is $42.5 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

8.9 m6.2 m6.4 m

Revenue growth, %

(31%)4%

Cost of goods sold

5.2 m3.2 m3.4 m

Gross profit

3.8 m3 m3.8 m

Gross profit Margin, %

42%49%59%

Sales and marketing expense

3 m

R&D expense

2 m

General and administrative expense

4.6 m

Operating expense total

4 m6.2 m8.8 m9.6 m

EBIT

(285.4 k)(3.1 m)(5 m)(4.9 m)

EBIT margin, %

(3%)(51%)(78%)

Interest expense

742.2 k177.3 k

Interest income

20.8 k2.4 k

Net Income

(1.1 m)(3.3 m)(5 m)(8 m)
USDQ2, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cost of goods sold

678.1 k771 k872.8 k920.9 k928.4 k

Sales and marketing expense

642.5 k733.9 k849.2 k816 k511.9 k

R&D expense

301.3 k504.2 k599 k496.9 k286.8 k

General and administrative expense

1 m1.3 m1.3 m1 m1.1 m

Operating expense total

2 m2.6 m2.7 m2.4 m1.9 m

EBIT

(1.2 m)(1.5 m)(1.6 m)(1.1 m)(464 k)

Interest income

5.5 k1.9 k4453048

Net Income

(2.3 m)(1.5 m)(3.2 m)(4.5 m)(870.3 k)
USDFY, 2015FY, 2016

Cash

2.2 m1.4 m

Inventories

1.8 m1.8 m

Current Assets

7 m4.6 m

Total Assets

12.4 m7.9 m

Accounts Payable

1 m710.7 k

Current Liabilities

1.7 m1.1 m

Total Liabilities

4.8 m

Additional Paid-in Capital

72.8 m74.4 m

Retained Earnings

(64.3 m)(71.2 m)

Total Equity

9.9 m3.2 m

Financial Leverage

1.3 x2.5 x
USDQ2, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

3.9 m1.7 m1.3 m1.4 m2.3 m

Inventories

1.3 m2 m1.9 m1.9 m1.8 m

Current Assets

9.3 m5.3 m4.9 m5 m5.6 m

Total Assets

13.9 m10.8 m10.6 m10.8 m8.6 m

Accounts Payable

640.3 k772.9 k864.5 k1.1 m638 k

Current Liabilities

1.2 m1.5 m2.3 m3.5 m1.1 m

Additional Paid-in Capital

72.1 m73 m73.7 m74 m74.9 m

Retained Earnings

(62.1 m)(65.6 m)(66.9 m)(67.9 m)(72.1 m)

Total Equity

11.9 m8.5 m7.5 m6.6 m2.8 m

Financial Leverage

1.2 x1.3 x1.4 x1.6 x3.1 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(1.1 m)(3.3 m)(5 m)(8 m)

Depreciation and Amortization

343.2 k368.1 k

Inventories

(869.4 k)(290.8 k)

Accounts Payable

194.4 k233.5 k

Cash From Operating Activities

(40.2 k)2.4 m(5 m)(4.3 m)

Purchases of PP&E

(134 k)(143.5 k)

Cash From Investing Activities

4.2 m392.8 k

Cash From Financing Activities

3.2 m
USDQ2, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(2.3 m)(1.5 m)(3.2 m)(4.5 m)(870.3 k)

Depreciation and Amortization

168.7 k91.8 k183.9 k276.3 k89.5 k

Inventories

(183.6 k)(76.1 k)(69.1 k)(54.4 k)

Accounts Payable

(99.8 k)91.9 k207.4 k361.9 k(12 k)

Cash From Operating Activities

(2.5 m)(1.6 m)(2.8 m)(3.7 m)(169.3 k)

Purchases of PP&E

(72 k)(26.9 k)(99.4 k)(130.1 k)(37.2 k)

Cash From Investing Activities

1.1 m662.4 k(37.2 k)

Cash From Financing Activities

12.1 k1.1 m2.2 m1.1 m
Y, 2017

Financial Leverage

3.1 x

BioLife Solutions Market Value History

BioLife Solutions Online and Social Media Presence

BioLife Solutions Company Life and Culture

You may also be interested in